Skip to main content

Advertisement

Log in

Variation in Receipt of Cancer Screening and Immunizations by 10-year Life Expectancy among U.S. Adults aged 65 or Older in 2019

  • Original Research
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Abstract

Importance

The likelihood of benefit from a preventive intervention in an older adult depends on its time-to-benefit and the adult’s life expectancy. For example, the time-to-benefit from cancer screening is >10 years, so adults with <10-year life expectancy are unlikely to benefit.

Objective

To examine receipt of screening for breast, prostate, or colorectal cancer and receipt of immunizations by 10-year life expectancy.

Design

Analysis of 2019 National Health Interview Survey.

Participants

8,329 non-institutionalized adults >65 years seen by a healthcare professional in the past year, representing 46.9 million US adults.

Main Measures

Proportions of breast, prostate, and colorectal cancer screenings, and immunizations, were stratified by 10-year life expectancy, estimated using a validated mortality index. We used logistic regression to examine receipt of cancer screening and immunizations by life expectancy and sociodemographic factors.

Key Results

Overall, 54.7% of participants were female, 41.4% were >75 years, and 76.4% were non-Hispanic White. Overall, 71.5% reported being current with colorectal cancer screening, including 61.4% of those with <10-year life expectancy. Among women, 67.0% reported a screening mammogram in the past 2 years, including 42.8% with <10-year life expectancy. Among men, 56.8% reported prostate specific antigen screening in the past two years, including 48.3% with <10-year life expectancy. Reported receipt of immunizations varied from 72.0% for influenza, 68.8% for pneumococcus, 57.7% for tetanus, and 42.6% for shingles vaccination. Lower life expectancy was associated with decreased likelihood of cancer screening and shingles vaccination but with increased likelihood of pneumococcal vaccination.

Conclusions

Despite the long time-to-benefit from cancer screening, in 2019 many US adults age >65 with <10-year life expectancy reported undergoing cancer screening while many did not receive immunizations with a shorter time-to-benefit. Interventions to improve individualization of preventive care based on older adults’ life expectancy may improve care of older adults.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

Similar content being viewed by others

References

  1. Lee SJ, Leipzig RM, Walter LC. Incorporating lag time to benefit into prevention decisions for older adults. JAMA. 2013;310(24):2609-10. doi:10.1001/jama.2013.282612

  2. Lee SJ, Boscardin WJ, Stijacic-Cenzer I, Conell-Price J, O'Brien S, Walter LC. Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark. BMJ. 2013;346:e8441. doi:10.1136/bmj.e8441

  3. Royce TJ, Hendrix LH, Stokes WA, Allen IM, Chen RC. Cancer screening rates in individuals with different life expectancies. JAMA Intern Med. 2014;174(10):1558-65. doi:https://doi.org/10.1001/jamainternmed.2014.3895

    Article  PubMed  Google Scholar 

  4. Schonberg MA, Marcantonio ER, Ngo L, Li D, Silliman RA, McCarthy EP. Causes of death and relative survival of older women after a breast cancer diagnosis. J Clin Oncol. 2011;29(12):1570-7. doi:10.1200/JCO.2010.33.0472

  5. Adult Vaccination Coverage — United States, 2010. Centers for Disease Control and Prevention. Accessed March 21, 2023, https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6104a2.htm

  6. Bonten MJ, Huijts SM, Bolkenbaas M, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med. 2015;372(12):1114-25. doi:10.1056/NEJMoa1408544

  7. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(1):36-44. doi:https://doi.org/10.1016/S1473-3099(11)70295-X

    Article  PubMed  Google Scholar 

  8. Code of Federal Regulations. Title 42. Accessed March 25, 2023, https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-410/subpart-B/section-410.15

  9. American Geriatrics Society: Ten Things Clinicians and Patients Should Question. Choosing Wisely: An Initiative of the ABIM Foundation. https://www.choosingwisely.org/societies/american-geriatrics-society/

  10. Cook NR, Rosner BA, Hankinson SE, Colditz GA. Mammographic screening and risk factors for breast cancer. Am J Epidemiol. 2009;170(11):1422-32. doi:10.1093/aje/kwp304

  11. Oeffinger KC, Fontham ET, Etzioni R, et al. Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. JAMA. 2015;314(15):1599-614. doi:https://doi.org/10.1001/jama.2015.12783

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Rex DK, Boland CR, Dominitz JA, et al. Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017;153(1):307-323. doi:https://doi.org/10.1053/j.gastro.2017.05.013

    Article  PubMed  Google Scholar 

  13. Carter HB, Albertsen PC, Barry MJ, et al. Early detection of prostate cancer: AUA Guideline. J Urol. 2013;190(2):419-26. doi:https://doi.org/10.1016/j.juro.2013.04.119

    Article  PubMed  PubMed Central  Google Scholar 

  14. Alex Smith MMM, Eric Widera, MD, Sei Lee, MD MAS, Mara Schonberg, MD MPH, Nancy Shoenborn, MD MHS, Lindsey Yourman, MD. ePrognosis. University of California San Francisco Accessed 01/28/23, 2023. https://eprognosis.ucsf.edu/calculators/

  15. Yourman LC LS, Schonberg MA, Widera EW, Smith AK. Prognostic indices for older adults: a systematic review. JAMA. January 11, 2012;11(307):182-92. doi:doi: 10.1001/jama.2011.1966

  16. Schonberg MA, Li V, Marcantonio ER, Davis RB, McCarthy EP. Predicting Mortality up to 14 Years Among Community-Dwelling Adults Aged 65 and Older. J Am Geriatr Soc. 2017;65(6):1310-1315. doi:https://doi.org/10.1111/jgs.14805

    Article  PubMed  PubMed Central  Google Scholar 

  17. Schonberg MA, Davis RB, McCarthy EP, Marcantonio ER. Index to predict 5-year mortality of community-dwelling adults aged 65 and older using data from the National Health Interview Survey. J Gen Intern Med. 2009;24(10):1115-22. doi:https://doi.org/10.1007/s11606-009-1073-y

    Article  PubMed  PubMed Central  Google Scholar 

  18. Schonberg MA, Davis RB, McCarthy EP, Marcantonio ER. External validation of an index to predict up to 9-year mortality of community-dwelling adults aged 65 and older. J Am Geriatr Soc. 2011;59(8):1444-51. doi:https://doi.org/10.1111/j.1532-5415.2011.03523.x

    Article  PubMed  PubMed Central  Google Scholar 

  19. Siu AL. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2016;164(4):279-96. doi:10.7326/M15-2886

  20. USPST, Grossman DC, Curry SJ, et al. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. May 8 2018;319(18):1901-1913. doi:10.1001/jama.2018.3710

  21. Force USPST, Davidson KW, Barry MJ, et al. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(19):1965-1977. doi:10.1001/jama.2021.6238

  22. Schoenborn NL, Boyd CM, Pollack CE. Impact of the COVID-19 pandemic on cancer screening attitudes, intentions, and behaviors in older adults. J Am Geriatr Soc. 2022;70(1):67-69. doi:https://doi.org/10.1111/jgs.17449

    Article  PubMed  Google Scholar 

  23. McBain RK, Cantor JH, Jena AB, Pera MF, Bravata DM, Whaley CM. Decline and Rebound in Routine Cancer Screening Rates During the COVID-19 Pandemic. J Gen Intern Med. 2021;36(6):1829-1831. doi:https://doi.org/10.1007/s11606-021-06660-5

    Article  PubMed  PubMed Central  Google Scholar 

  24. Fillon M. Routine Cancer Screening Rates Rebound After Deep Drop From Pandemic Fear. CA Cancer J Clin. 2021;71(5):366-368. doi:https://doi.org/10.3322/caac.21692

    Article  PubMed  PubMed Central  Google Scholar 

  25. Lal H, Cunningham AL, Godeaux O, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372(22):2087-96. doi:10.1056/NEJMoa1501184

  26. Statistics NCFH. Preliminary evaluation of the impact of the 2019 National Health Interview Survey questionnaire redesign and weighting adjustments on Early Release Program estimates. Accessed 01/28/2023, 2023. https://www.cdc.gov/nchs/data/nhis/earlyrelease/EReval202009-508.pdf

  27. Shoenborn NL LK, Pollack CE, Armacost K, Dy SM, Bridges JFP, Xue QL, Wolff AC, Boyd C. Older Adults' Views and Communication Preferences About Cancer Screening Cessation. JAMA Intern Med. 2017;177(8):1121-1128. doi:doi: 10.1001/jamainternmed.2017.1778

  28. Schonberg MA, Breslau ES, McCarthy EP. Targeting of mammography screening according to life expectancy in women aged 75 and older. J Am Geriatr Soc. 2013;61(3):388-95. doi:https://doi.org/10.1111/jgs.12123

    Article  PubMed  PubMed Central  Google Scholar 

  29. Recommendations for Ages 19 Years or Older, United States, 2023. Centers for Disease Control and Prevention. Accessed March 13, 2023, https://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html#table-age

  30. Ganguli I, Souza J, McWilliams JM, Mehrotra A. Association Of Medicare's Annual Wellness Visit With Cancer Screening, Referrals, Utilization, And Spending. Health Aff (Millwood). 2019;38(11):1927-1935. doi:https://doi.org/10.1377/hlthaff.2019.00304

    Article  PubMed  PubMed Central  Google Scholar 

  31. Schonberg MA, Breslau ES, Hamel MB, Bellizzi KM, McCarthy EP. Colon cancer screening in U.S. adults aged 65 and older according to life expectancy and age. J Am Geriatr Soc. 2015;63(4):750-6. doi:https://doi.org/10.1111/jgs.13335

    Article  PubMed  Google Scholar 

  32. Star J, Bandi P, Siegel RL, et al. Cancer Screening in the United States During the Second Year of the COVID-19 Pandemic. J Clin Oncol. Feb 23 2023:JCO2202170. doi:10.1200/JCO.22.02170

  33. Usage Note 23003: Estimating a relative risk (also called risk ratio, prevalence ratio). SAS Support. Accessed 07/28/2023, 2023. https://support.sas.com/kb/23/003.html

  34. Coll PP, Batsis JA, Friedman SM, Flaherty E. Medicare's annual wellness visit: 10 years of opportunities gained and lost. J Am Geriatr Soc. 2022;70(10):2786-2792. doi:https://doi.org/10.1111/jgs.18007

    Article  PubMed  Google Scholar 

  35. Schoenborn NL, Huang J, Sheehan OC, Wolff JL, Roth DL, Boyd CM. Influence of Age, Health, and Function on Cancer Screening in Older Adults with Limited Life Expectancy. J Gen Intern Med. 2019;34(1):110-117. doi:https://doi.org/10.1007/s11606-018-4717-y

    Article  PubMed  Google Scholar 

  36. Moyer VA. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Annals of Internal Medicine. 2012;157(2):120-134. doi:https://doi.org/10.7326/0003-4819-157-2-201207170-00459

    Article  PubMed  Google Scholar 

  37. Span P. Aging Out of the Mammogram. New York Times. March 16, 2020. Accessed August 2, 2023. https://www.nytimes.com/2020/03/16/health/breastcancer-elderly-old-age.html

  38. Span P. Mammography’s Limits, Seldom Understood. New York Times. March 14, 2014. Accessed August 2, 2023. https://archive.nytimes.com/newoldage.blogs.nytimes.com/2014/03/14/mammographys-limits-seldom-understood/

  39. Harris G. U.S. Panel Says No to Prostate Screening for Healthy Men. New York Times. Accessed August 2, 2023. https://www.nytimes.com/2011/10/07/health/07prostate.html

  40. Rabin RC. Cancer Group Calls for Colorectal Cancer Screening Starting at Age 45. New York Times. Accessed August 2, 2023. https://www.nytimes.com/2018/05/30/well/cancer-group-calls-for-colorectal-cancer-screening-starting-at-age-45.html

  41. Calderwood AH, Tosteson TD, Walter LC, Hua P, Onega T. Colonoscopy utilization and outcomes in older adults: Data from the New Hampshire Colonoscopy Registry. J Am Geriatr Soc. 2022;70(3):801-811. doi:https://doi.org/10.1111/jgs.17560

    Article  PubMed  Google Scholar 

  42. Reduced Drug Prices, Enhanced Medicare Benefits Under the Inflation Reduction Act Frequently Asked Questions (FAQs). Centers for Medicare and Medicaid Services. Accessed March 25, 2023, https://www.cms.gov/files/document/10522-external-faqs-about-inflation-reduction-act.pdf

  43. Balestra DJ, Littenberg B. Should adult tetanus immunization be given as a single vaccination at age 65? A cost-effectiveness analysis. J Gen Intern Med. 1993;8(8):405-12. doi:https://doi.org/10.1007/BF02599616

    Article  CAS  PubMed  Google Scholar 

  44. Hsiao A, Klein NP. All Older Adults Benefit From Pneumococcal Vaccinations-The Case for Evaluating Vaccine Effectiveness Using All-Cause Pneumonia. JAMA Intern Med. 2023;183(1):48-49. doi:10.1001/jamainternmed.2022.5456

  45. Jiang M, Hughes DR, Wang W. The effect of Medicare's Annual Wellness Visit on preventive care for the elderly. Prev Med. 2018;116:126-133. doi:https://doi.org/10.1016/j.ypmed.2018.08.035

    Article  PubMed  Google Scholar 

  46. Tao G. Utilization pattern of other preventive services during the US Medicare annual wellness visit. Prev Med Rep. 2018;10:210-211. doi:https://doi.org/10.1016/j.pmedr.2017.12.014

    Article  PubMed  Google Scholar 

  47. Camacho F, Yao NA, Anderson R. The Effectiveness of Medicare Wellness Visits in Accessing Preventive Screening. J Prim Care Community Health. 2017;8(4):247-255. doi:https://doi.org/10.1177/2150131917736613

    Article  ADS  PubMed  PubMed Central  Google Scholar 

  48. Roy S MJ, Rodriguez-Colon SM, Shen C, Cooper JD, Lennon RP, Lengerich EJ, Adelman A, Curry W, Ruffin MT 4th. Examining Older Adults' Attitudes and Perceptions of Cancer Screening and Overscreening: A Qualitative Study. J Prim Care Community Health. Jan-Dec 2020 2020;11:2150132720959234. doi:10.1177/2150132720959234

  49. Smith J DR, Gainey KM, Naganathan V, Cvejic E, Jansen J, McCaffery KJ. Patient-Reported Factors Associated With Older Adults' Cancer Screening Decision-making: A Systematic Review. JAMA Netw Open. 2021;4(11):e2133406. doi:10.1001/jamanetworkopen.2021.33406

  50. Schoenborn NL LK, Pollack CE, Armacost K, Dy SM, Bridges JFP, Xue QL, Wolff AC, Boyd C. Older Adults' Views and Communication Preferences About Cancer Screening Cessation. JAMA Intern Med. August 1, 2017 2017;177(8):1121-1128. doi:10.1001/jamainternmed.2017.1778

  51. Schonberg MA KM, Jacobson AR, Aliberti GM, Pinheiro A, Smith AK, Davis RB, Schuttner LC, Hamel MB. A Strategy to Prepare Primary Care Clinicians for Discussing Stopping Cancer Screening With Adults Older Than 75 Years. Innov Aging. 2020;4(4):igaa027. doi:10.1093/geroni/igaa027

  52. Schonberg MA, Jacobson AR, Karamourtopoulos M, et al. Scripts and Strategies for Discussing Stopping Cancer Screening with Adults > 75 Years: a Qualitative Study. J Gen Intern Med. 2020;35(7):2076-2083. doi:10.1007/s11606-020-05735-z

  53. Schonberg M, Kistler CE, Pinheiro A, Jacobson AR, Aliberti GM, Karamourtopoulos M, Hayes M, Neville BA, Lewish CL, Wee CC, Fagerline A, Nekhlyudov L, Marcantonio ER, Hamel MB, Davis RB. Effect of a Mammography Screening Decision Aid for Women 75 Years and Older. JAMA Intern Med. 2020;180(6):831-842. doi:https://doi.org/10.1001/jamainternmed.2020.0440

    Article  PubMed  PubMed Central  Google Scholar 

  54. Jindal SK KM, Jacobson AR, Pinheiro A, Smith AK, Hamel MB, Schonberg MA. Strategies for discussing long-term prognosis when deciding on cancer screening for adults over age 75. J Am Geriatr Soc. 2022;70(6):1734-1744. doi:10.1111/jgs.17723

  55. Schoenborn NL, Huang J, Boyd CM, Pollack CE. Racial Disparities Vary by Patient Life Expectancy in Screening for Breast, Prostate, and Colorectal Cancers. J Gen Intern Med. 2020;35(11):3389-3391. doi:https://doi.org/10.1007/s11606-019-05566-7

    Article  PubMed  Google Scholar 

  56. Park S, Chen J, Ma GX, Ortega AN. Utilization of essential preventive health services among Asians after the implementation of the preventive services provisions of the Affordable Care Act. Prev Med Rep 2019;16:101008. doi:https://doi.org/10.1016/j.pmedr.2019.101008

    Article  PubMed  PubMed Central  Google Scholar 

  57. Jamison AM, Quinn SC, Freimuth VS. "You don't trust a government vaccine": Narratives of institutional trust and influenza vaccination among African American and white adults. Soc Sci Med. 2019;221:87-94. doi:https://doi.org/10.1016/j.socscimed.2018.12.020

    Article  PubMed  Google Scholar 

  58. Martinez ML CS. Addressing Immunization Health Disparities. Prim Care. 2020;47(3)doi:doi: 10.1016/j.pop.2020.05.004

  59. Rauscher GH, Johnson TP, Cho YI, Walk JA. Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008;17(4):748-57. doi:https://doi.org/10.1158/1055-9965.EPI-07-2629

    Article  PubMed  Google Scholar 

  60. Doan C, Li S, Goodwin JS. Breast and Lung Cancer Screening Among Medicare Enrollees During the COVID-19 Pandemic. JAMA Netw Open. 2023;6(2):e2255589. doi:10.1001/jamanetworkopen.2022.55589

  61. Cruz M CK, Widera EW, Stijacic-Cenzer I, Lee SJ. Predicting 10-year mortality for older adults. JAMA. 2013;309(9):874-6. doi:https://doi.org/10.1001/jama.2013.1184

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Pollack CE BA, Schoenborn NL, Boyd CM, Peairs KS, DuGoff EH. Comparing Prognostic Tools for Cancer Screening: Considerations for Clinical Practice and Performance Assessment. J Am Geriatr Soc. 2016;64(5):1032-8. doi:https://doi.org/10.1111/jgs.14089

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

Dr. Schonberg’s time on this project was supported by a NIH/NIA K24 (AG071906). Dr. Schoenborn’s time on this project was supported by NIH/NIA K76 (AG059984).

Author information

Authors and Affiliations

Authors

Contributions

Lindsey Yourman, MD: contributed to the conception of the work, drafting and revising, approval of the final version, and is accountable for the study integrity. Jaclyn (Nikki) Bergstrom, M.S.: contributed to the design of the work, data analysis and interpretation, drafting of the work, approval of the final version, and is accountable for the study integrity. Elizabeth A. Bryant, MD, MPH: contributed to the interpretation of the data, draft, approval of the final version, and is accountable for the study integrity. Alina Pollner: contributed to the data analysis and interpretation, draft of the work, approval of the final version, and is accountable for the study integrity. Alison A. Moore MD, MPH: contributed to the design of the work, interpretation of data, critical revisions for important content, approval of the final version, and is accountable for the study integrity. Nancy Li Schoenborn, MD, MHS: contributed to the conception of the work, interpretation of data, critical revisions for important content, approval of the final version, and is accountable for the study integrity. Mara A. Schonberg, MD, MPH: contributed to the conception and design of the work, acquisition, and interpretation of data, drafting and revising, approval of the final version, and is accountable for the study integrity. All authors have access to the publicly available National Health Interview Survey upon which our study is based.

Corresponding author

Correspondence to Lindsey C. Yourman MD.

Ethics declarations

Conflict of interest

All authors have no conflicts of interest to report.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

ESM 1

(DOCX 383 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yourman, L.C., Bergstrom, J., Bryant, E.A. et al. Variation in Receipt of Cancer Screening and Immunizations by 10-year Life Expectancy among U.S. Adults aged 65 or Older in 2019. J GEN INTERN MED 39, 440–449 (2024). https://doi.org/10.1007/s11606-023-08439-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11606-023-08439-2

KEY WORDS

Navigation